This cross-sectional study examined the distribution of HPV 58 sequence variation in Korean women for the first time. Among 1,750 Korean women, 53 women were positive for HPV 58 single infection, of whom 26 were without disease, 20 were with cervical intraepithelial neoplasia (CIN) 1, and 7 with CIN 2 or 3. Altogether, 36 different nucleotide sequence variations were identified with the L1, 20 within E2, 5 within E6, and 10 within E7. Further studies on variants of oncogenic HPVs are necessary, particularly for the purpose of developing more predictive HPV detection methods.
High-risk human papillomavirus (HPV) is necessary for the development of cervical cancer and their precursor, cervical intraepithelial neoplasia (CIN). HPV 16 and 18 account for about 70% of all cervical cancers worldwide, whereas HPV 58 infections occur in only 2% [1, [3] [4] [5] [6] [7] [8] 13] . The relative importance of other oncogenic HPV types differs by region, and HPV 58 is particularly prevalent in northeastern Asian and Korean women [1] .
Generally, two HPV isolates are classified as different types when the nucleotide sequences of their L1 open reading frames (ORFs) differ by more than 10%, whereas isolates differing by 2-10% are considered as subtypes, and those differing by less than 2% are considered as variants [8, 15] . Most HPV variant analyses have focused on HPV 16 and 18, the most prevalent oncogenic types worldwide [2, 9, 10, 12, 16] . In this study, we aimed to analyze the sequence variations of HPV 58, the third most common genotype in Korean women.
This analysis was part of a prospective study for a hospital-based cervical cancer screening program conducted between January 2002 and July 2006. Samples from cervical cytology were collected during clinical examination. When either gynecological examination or colposcopy revealed suspicious cervical lesions, cervical biopsies were performed.
HPV genotyping was performed using the HPV DNA oligonucleotide chip (Mygene Co., Seoul, Korea), which consisted of 22 type-specific probes, including 15 in the high-risk group (16, 18, 31, 33, 35, 39, 45 , 51, 52, 56, 58, 59, 66, 68, and 69) and 7 in the low-risk group (6, 11, 34, 40, 42, 43 , and 44).
The ORFs including E2, E6, E7, and L1 of HPV 58 were amplified based on specific primers designed using the HPV 58 prototype (GenBank Accession No. D90400). 
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. The HPV 58 prototype (GenBank Accession No. D90400) was used as the reference for identifying sequence variations. Distributions of HPV 58 variations with respect to disease severity were examined by the exact MantelHaenszel's linear trend test (P trend ) and Fisher's exact test (P). A P-value less than 0.05 was considered significant.
A total of 1,750 Korean women aged 15-75 years were included, with informed consent from each patient. Four hundred seventy-three patients were HPV DNA positive, and 78 tested positive for HPV 58. To exclude the possibility that multiple HPV infections may confound the results of the analysis, a total of 53 women (median age, 42 years; range, 15-71 years) with HPV 58 single infection were included. Of these, 26 patients had normal cytology, 20 had CIN 1, and 7 had CIN 2 or 3.
At the nucleotide level, 36 variants of L1, 20 variants of E2, 5 variants of E6, and 10 variants of E7 were identified in a total of 44 patients (83.0%). HPV 58 L1 gene sequence variants were identified in 40 samples (75.5%). Of the HPV 58 gene variants identified, 28 resulted in missense mutations: 12 in L1, 7 in E2, 3 in E6, and 6 in E7. The most prevalent amino acid changes were in L1 (L5F, L150F, and I325M), E2 (S279A and V282L), and E7 (T20I and G63S). E2 S279A and E2 V282L missense mutations were consistently found in association, suggesting a possible linkage between the two mutations. Based on grouping of variants according to cervical neoplasia severity (Tables 2 and 3) , there was no significant association. This study represents the first analysis of HPV 58 variants in a cohort of Korean women. Because this was a cross-sectional study, any estimation of risk should be interpreted with caution. A previous study of HPV 16 in Korean women indicated a relationship between one HPV 16 E7 variant (N29S) and invasive cervical cancer [14] . However, in other more recent Korean studies, there was no significant relationship between the risk of cervical disease progression and HPV 16 variants [4, 11] . The lower prevalence of oncogenic HPVs other than HPV 16 and 18 makes further variant analyses more problematic.
The distribution of HPV variants appears to be related to geographic regions and differences in oncogenic potential [2, 9, 10, 12, 16] . The diversity of oncogenic potential of high-risk HPV variants may be generated by alteration of coding or regulatory elements within the genomes [2, 9, 12] . Despite the current understanding of the roles of individual HPV proteins, the detailed mechanisms used by specific HPV variants to increase oncogenic potential are not well understood and warrant further investigation on a larger scale. 
